Invention Publication
- Patent Title: HERPES SIMPLEX VIRUS VACCINE
-
Application No.: US18354574Application Date: 2023-07-18
-
Publication No.: US20240156952A1Publication Date: 2024-05-16
- Inventor: Giuseppe Ciaramella , Shinu John , Andrew J. Bett , Danilo R. Casimiro , Dai Wang , Lan Zhang
- Applicant: ModernaTX, Inc.
- Applicant Address: US MA Cambridge
- Assignee: ModernaTX, Inc.
- Current Assignee: ModernaTX, Inc.
- Current Assignee Address: US MA Cambridge
- Main IPC: A61K39/245
- IPC: A61K39/245 ; A61K9/00 ; A61K9/51 ; A61K39/39 ; A61K47/69 ; A61P31/22 ; C07K14/005 ; C12N7/00
Abstract:
Herpes simplex virus (HSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines. In a preferred embodiment, the vaccine is formulated as a lipid nanoparticle comprising at least one cationic lipid.
Information query
